Document Detail


Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosis.
MedLine Citation:
PMID:  22296196     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
New circulating and local arterial biomarkers may help the clinician with risk stratification or diagnostic assessment of patients and selecting the proper therapy for a patient. In addition, they may be used for follow-up and testing efficacy of therapy, which is not possible with current biomarkers. Processes leading to postinterventional restenosis and accelerated atherosclerosis are complex due to the many biological variables mediating the specific inflammatory and immunogenic responses involved. Adequate assessment of these processes requires different and more specific biomarkers. Postinterventional remodeling is associated with cell stress and tissue damage causing apoptosis, release of damage-associated molecular patterns and upregulation of specific cytokines/chemokines that could serve as suitable clinical biomarkers. Furthermore, plasma titers of pathophysiological process-related (auto)antibodies could aid in the identification of restenosis risk or lesion severity. This review provides an overview of a number of potential biomarkers selected on the basis of their role in the remodeling process.
Authors:
Jacco C Karper; Mark M Ewing; J Wouter Jukema; Paul Ha Quax
Related Documents :
18407066 - Mycobacterium tuberculosis prevents inflammasome activation.
11254636 - Antimycobacterial agent based on mrna encoding human beta-defensin 2 enables primary ma...
21897106 - Pro- and anti-inflammatory cytokine expression and histopathological characteristics in...
19302046 - Cell-mediated immune responses in tuberculosis.
9244236 - Downregulation of cyclin g1 expression by retrovirus-mediated antisense gene transfer i...
22361726 - Mkp-1 coordinates ordered macrophage-phenotype transitions essential for stem cell-depe...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biomarkers in medicine     Volume:  6     ISSN:  1752-0371     ISO Abbreviation:  Biomark Med     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101312535     Medline TA:  Biomark Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  53-66     Citation Subset:  IM    
Affiliation:
Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronar...
Next Document:  Correlation of peripheral arterial blood flow with plasma chemerin and VEGF in diabetic peripheral v...